Transformation by Rous sarcoma virus: effects of src gene expression on the synthesis and phosphorylation of cellular

Insights

Rous sarcoma virus infection alters cellular protein synthesis and phosphorylation. A specific 36,000 Mr phosphoprotein emerges early in viral transformation, potentially targeted by pp60src kinase.

Area of Science:

  • Cell Biology
  • Virology
  • Molecular Biology

Background:

  • Rous sarcoma virus (RSV) infection causes significant changes in chicken embryo fibroblast growth and morphology.
  • Understanding the molecular mechanisms of viral transformation is crucial for cancer research.

Purpose of the Study:

  • To investigate the effects of RSV infection on cellular polypeptide synthesis and phosphorylation.
  • To identify specific protein alterations associated with viral transformation.

Main Methods:

  • Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) was employed to analyze protein synthesis and phosphorylation patterns.
  • [35S]methionine and [32P]orthophosphate labeling were used to track newly synthesized and phosphorylated proteins, respectively.
  • Experiments utilized a temperature-sensitive mutant of RSV to study early transformation events.

Main Results:

  • RSV infection did not induce significant de novo synthesis or complete suppression of major cellular polypeptides.
  • Quantitative changes were observed in a small fraction (approx. 4%) of [35S]methionine-labeled polypeptides.
  • A 36,000 Mr phosphoprotein was detected in RSV-transformed cells, appearing rapidly upon temperature shift in cells infected with a temperature-sensitive mutant.

Conclusions:

  • Viral transformation by RSV leads to subtle quantitative changes in protein synthesis but significant alterations in protein phosphorylation.
  • The early appearance of the 36,000 Mr phosphoprotein suggests its role as an early event in transformation.
  • This phosphoprotein is a potential target for the kinase activity of pp60src, a key viral oncoprotein.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...